Walter & Keenan Wealth Management LLC Gilead Sciences, Inc. Transaction History

Walter & Keenan Wealth Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 27, 2020	SELL	$62.1 - $78.08 $172,638 - $217,062	-2,780 Closed	0 $0
Q2 2020 Jul 16, 2020	BUY	$72.34 - $84.0 $201,105 - $233,520	2,780 New	2,780 $214,000
Q1 2019 May 08, 2019	SELL	$62.53 - $70.05 $204,473 - $229,063	-3,270 Closed	0 $0
Q4 2018 Feb 01, 2019	SELL	$60.54 - $79.0 $60,540 - $79,000	-1,000 Reduced 23.42%	3,270 $205,000
Q3 2018 Oct 29, 2018	SELL	$71.28 - $78.92 $71,280 - $78,920	-1,000 Reduced 18.98%	4,270 $330,000
Q2 2018 Aug 09, 2018	SELL	$64.88 - $75.68 $53,850 - $62,814	-830 Reduced 13.61%	5,270 $373,000
Q1 2018 May 04, 2018	SELL	$72.84 - $88.8 $5,098 - $6,216	-70 Reduced 1.13%	6,100 $460,000
Q4 2017 Jan 23, 2018	SELL	$71.15 - $83.52 $44,824 - $52,617	-630 Reduced 9.26%	6,170 $442,000
Q3 2017 Nov 08, 2017	BUY	$72.11 - $85.47 $490,348 - $581,196	6,800	6,800 $551,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Walter & Keenan Wealth Management LLC , based on Form 13F filings with the SEC.

Stay updated on Walter & Keenan Wealth Management LLC with notifications on news.